跳至主要内容
临床试验/NCT03204682
NCT03204682Unknown不适用

Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility Study

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2016年4月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
24
试验地点
1
主要终点
Percentage of patients tolerant 5 sessions of stimulation and with no increase in pain

研究概览

简要总结

Endometriosis is associated with different types of pain (acute, chronic, excess nociception, neuropathic) generated by different mechanisms in the nervous system. The rTMS could provide significant analgesia for refractory endometriosis pain.

The aim of the study is to evaluate the feasibility of transcranial magnetic stimulation (rTMS) for analgesia on chronic refractory endometriosis pain.

详细描述

The first step consists of the inclusion of 12 patients followed by the filling by each patient of the RedCap software of five simple numerical scales for 4 weeks . Realization of a brain and medullary MRI to allow neuronavigation. Realization of 5 sessions of rTMS in 5 days during the first week then evaluation (physical examination, questionnaires) in consultation on post-stimulation. Then followed for 28 days in total through self-assessment of pain that will be filled daily on REDCap and last consultation on D28 for further evaluation

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

Open

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Premenopausal (presence of at least one of the two ovaries and absence of clinical signs of menopause),
  • •Not pregnant or breastfeeding;
  • •At least one painful symptoms related to the existence of endometriosis (dyspareunia, dysmenorrhea, pain with defecation or urination, neuropathic pain);
  • •Average VAS> 4/10, at least 4 days out of 7 for at least 3 months;
  • •Hormonal treatment failure continued in association or not for pain control;
  • •A level of understanding and satisfying expression in French;
  • •Monitoring possible during the duration of the study (4 weeks).
  • •These patients should be affiliated to the French social security and should have signed a written consent after receiving clear information.

排除标准

  • •Prior treatment with rTMS,
  • •Industrial accident or notion of litigation
  • •Cons-indication for rTMS (cortical lesion within 2cm of the motor cortex, ECT treatment during previous month, epilepsy and / or a history of epilepsy, history of head trauma, intracranial hypertension;
  • •Metal clip; pacemaker,
  • •Pregnant or breastfeeding women;
  • •Pain lasting less than 3 months;
  • •Another pain more severe than that associated with endometriosis;
  • •Lack of filling of the computerized questionnaires on Redcap;
  • •Incapable of understanding about informed consent,
  • •Patient under guardianship.

研究组 & 干预措施

Patients with chronic refractory endometriosis pain

Experimental

The aim of the study is to evaluate the feasibility of transcranial magnetic stimulation (rTMS) for analgesia on chronic refractory endometriosis pain.

干预措施: Repetitive transcranial magnetic stimulation (Device)

结局指标

主要结局

Percentage of patients tolerant 5 sessions of stimulation and with no increase in pain

时间窗: at day 8

The feasibility of rTMS treatment was defined if 7 patients or more over 12 tolerate the 5 sessions of stimulation showed no increase in pain

次要结局

  • Endometriosis Health Profile Questionnaire (EPH-30);(at day 8)
  • Brief Pain Inventory (BPI): digital(at day 8)
  • Migraine criteria (ICHD3)(at day 8)
  • Gastrointestinal quality of Life Index (GICLI)(at day 8)
  • Change in pain between the mean pain evaluated before inclusion(at day 8)
  • Beck Questionnaire (Depression)(at day 8)
  • STAI of Anxiety Scale; Scale of alexythymie of Toronto(at day 8)
  • Catastrophizing Pain Scale (personality)(at day 8)
  • Quality of Life Questionnaire SF-36(at day 8)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验